Tirzepatide 10mg
Dual-agonist metabolic reset.
Reply within 24 hours.
Important — Research framing
For research purposes only. This compound is not approved for human use in Thailand or internationally outside of prescribed medical contexts. Protocol guidance is provided for informational purposes. Consult a qualified physician before initiating any injectable peptide protocol.
Mechanism
How it works.
Activates both GIP and GLP-1 receptors simultaneously — producing stronger appetite suppression and metabolic improvement than single-agonist protocols.
Tirzepatide is the most widely researched dual-agonist peptide in metabolic science. Research protocols consistently show meaningful body composition improvement over 8–12 week cycles. 10mg lyophilised vial, titration supply.
Research protocol
Titration schedule.
Reference titration based on published research protocols. We confirm your specific protocol fit in chat before fulfilment.
- Week 1–20.5mg
Starting dose. Allow full adaptation before increasing.
- Week 3–41.0mg
Increase only if tolerating well with no significant nausea.
- Week 5–61.5mg
- Week 7+2.0–2.5mg
Maintenance range for most research protocols. Higher doses available via consultation.
Order
Start Tirzepatide 10mg.
Message us on Telegram. We'll confirm fit, walk through the titration, and ship within 24 hours.